Marieke F Fransen

Author PubWeight™ 7.42^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.	Proc Natl Acad Sci U S A	2002	1.34
2	Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.	J Immunol	2004	1.29
3	Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors.	J Immunol	2012	1.14
4	The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment.	J Immunol	2004	1.10
5	CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.	Cancer Res	2005	0.89
6	Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction.	J Immunol	2004	0.84
7	Maintenance of immune tolerance depends on normal tissue homeostasis.	J Immunol	2005	0.82
8	Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer.	Curr Pharm Des	2015	0.75